Clinical Trials Directory

Trials / Unknown

UnknownNCT05635435

Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes

Preoperative Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes: A Prospective Multi-Institutional Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,282 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Our study considered the relevant immune and inflammatory indices, such as immunoglobulin kappa light chain, TNF, and CD4+ Helper T lymphocyte% in a multi-institutional study with a large patient cohort (n=1282) from the east, northeast, and southeast of China. Our study shed light on the association of peripheral immune system status with prognosis, tumor grade, and subtype of glioma, which can potentially benefit future diagnostic and prognostic processes of glioma given its noninvasive nature. Moreover, the preoperative inflammatory status can be leveraged for timely interventions to reverse the immunosuppressive status of cancer patients and enhance anti-tumour immunity of glioma.

Conditions

Interventions

TypeNameDescription
OTHERDetection of Immune and Inflammatory Indices in Peripheral BloodWe detected immune and inflammatory indices in peripheral blood at each patient's at first hospitalizatin from October 13th, 2006, to April 6th, 2022.

Timeline

Start date
2006-10-13
Primary completion
2022-04-06
Completion
2023-12-20
First posted
2022-12-02
Last updated
2023-07-12

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05635435. Inclusion in this directory is not an endorsement.